Oncogene - Table of Contents alert Volume 28 Issue 4

TABLE OF CONTENTS Volume 28, Issue 4 (January 2009) In this issue Original Articles Short Communication Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Cool new website, Hot science jobs! Naturejobs is pleased to announce naturejobs.com has a new and improved look and functionality, making your Naturejobs online experience even better! Check out our redesign and find thousands of scientific vacancies, careers information, podcasts, advertising options and more! www.naturejobs.com   Call for papers! Submit your best work inthefieldoncogenes, includingmechanism of activation, structure and function of encoded proteins;DNA and RNA tumor viruses andall other aspects of structure and function. Our online submission process is easy and can assist you in becoming part of this distinguished journal. To learn about the benefits of submitting your paper to Oncogene,visit www.nature.com/onc/for_authors   Original Articles Top A novel mouse model of hepatocarcinogenesis triggered by AID causing deleterious p53 mutations A Takai, T Toyoshima, M Uemura, Y Kitawaki, H Marusawa, H Hiai, S Yamada, I M Okazaki, T Honjo, T Chiba & K Kinoshita Oncogene 2009 28: 469-478; advance online publication, November 10, 2008; 10.1038/onc.2008.415 Abstract | Full Text Suppression of neuroblastoma growth by dipeptidyl peptidase IV: relevance of chemokine regulation and caspase activation W T Arscott, A E LaBauve, V May & U V Wesley Oncogene 2009 28: 479-491; advance online publication, November 3, 2008; 10.1038/onc.2008.402 Abstract | Full Text Hedgehog signaling promotes the degradation of tumor suppressor Sufu through the ubiquitin–proteasome pathway S Yue, Y Chen & S Y Cheng Oncogene 2009 28: 492-499; advance online publication, November 10, 2008; 10.1038/onc.2008.403 Abstract | Full Text Inhibition of pituitary tumors in Rb mutant chimeras through E2f4 loss reveals a key suppressive role for the pRB/E2F pathway in urothelium and ganglionic carcinogenesis T Parisi, R T Bronson & J A Lees Oncogene 2009 28: 500-508; advance online publication, November 10, 2008; 10.1038/onc.2008.406 Abstract | Full Text PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer C J Guigon, L Zhao, M C Willingham & S-Y Cheng Oncogene 2009 28: 509-517; advance online publication, November 10, 2008; 10.1038/onc.2008.407 Abstract | Full Text Disruption of the EGFR E884–R958 ion pair conserved in the human kinome differentially alters signaling and inhibitor sensitivity Z Tang, S Jiang, R Du, E T Petri, A El-Telbany, P S O Chan, T Kijima, S Dietrich, K Matsui, M Kobayashi, S Sasada, N Okamoto, H Suzuki, K Kawahara, T Iwasaki, K Nakagawa, I Kawase, J G Christensen, T Hirashima, B Halmos, R Salgia, T J Boggon, J A Kern & P C Ma Oncogene 2009 28: 518-533; advance online publication, November 17, 2008; 10.1038/onc.2008.411 Abstract | Full Text The uPA/uPAR system regulates the bioavailability of PDGF-DD: implications for tumour growth M Ehnman, H Li, L Fredriksson, K Pietras & U Eriksson Oncogene 2009 28: 534-544; advance online publication, November 10, 2008; 10.1038/onc.2008.410 Abstract | Full Text New p53 target, phosphatase of regenerating liver 1 (PRL-1) downregulates p53 S-H Min, D M Kim, Y-S Heo, Y-I Kim, H M Kim, J Kim, Y-M Han, I-C Kim & O-J Yoo Oncogene 2009 28: 545-554; advance online publication, November 10, 2008; 10.1038/onc.2008.409 Abstract | Full Text Increased nucleotide polymorphic changes in the 5'-untranslated region of -catenin (CTNND2) gene in prostate cancer T Wang, Y-H Chen, H Hong, Y Zeng, J Zhang, J-P Lu, B Jeansonne & Q Lu Oncogene 2009 28: 555-564; advance online publication, November 3, 2008; 10.1038/onc.2008.399 Abstract | Full Text Regulation of the hTERT promoter activity by MSH2, the hnRNPs K and D, and GRHL2 in human oral squamous cell carcinoma cells X Kang, W Chen, R H Kim, M K Kang & N-H Park Oncogene 2009 28: 565-574; advance online publication, November 17, 2008; 10.1038/onc.2008.404 Abstract | Full Text Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor–coregulator interactions J Wen, R Li, Y Lu & M A Shupnik Oncogene 2009 28: 575-586; advance online publication, November 10, 2008; 10.1038/onc.2008.405 Abstract | Full Text Palladin contributes to invasive motility in human breast cancer cells S M Goicoechea, B Bednarski, R García-Mata, H Prentice-Dunn, H J Kim & C A Otey Oncogene 2009 28: 587-598; advance online publication, November 3, 2008; 10.1038/onc.2008.408 Abstract | Full Text Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/-catenin pathway R-S Chen, Y-M Song, Z-Y Zhou, T Tong, Y Li, M Fu, X-L Guo, L-J Dong, X He, H-X Qiao, Q-M Zhan & W Li Oncogene 2009 28: 599-609; advance online publication, November 17, 2008; 10.1038/onc.2008.414 Abstract | Full Text Evaluation of the novel mitotic modulator ON 01910.Na in pancreatic cancer and preclinical development of an ex vivo predictive assay A Jimeno, A Chan, G Cusatis, X Zhang, J Wheelhouse, A Solomon, F Chan, M Zhao, S C Cosenza, MV Ramana Reddy, M A Rudek, P Kulesza, R C Donehower, E P Reddy & M Hidalgo Oncogene 2009 28: 610-618; advance online publication, November 24, 2008; 10.1038/onc.2008.424 Abstract | Full Text Short Communication Top Nitric oxide prodrug JS-K inhibits ubiquitin E1 and kills tumor cells retaining wild-type p53 J Kitagaki, Y Yang, J E Saavedra, N H Colburn, L K Keefer & A O Perantoni Oncogene 2009 28: 619-624; advance online publication, November 3, 2008; 10.1038/onc.2008.401 Abstract | Full Text Advertisement Ensure your access If you are unable to access the articles in this Table of Contents e-alert, your library may not subscribe to this journal. Our online recommendation form is a simple way to make your librarian aware that this journal is valuable to your research. Recommend now   More Nature Products More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2009 Nature Publishing Group